Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

CytoDyn Cash Flow from Operating Activities 2010-2024 | CYDY

CytoDyn cash flow from operating activities from 2010 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
  
CytoDyn Annual Cash Flow Ops
(Millions of US $)
2024 $-11
2023 $-25
2022 $-78
2021 $-118
2020 $-69
2019 $-50
2018 $-30
2017 $-27
2016 $-25
2015 $-12
2014 $-7
2013 $-3
2012 $-4
2011 $-2
2010 $-2
2009 $-1
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.160B $0.000B
CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of HIV infection. The Company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has completed Phase 2 clinical trials with demonstrated antiviral activity in humans and is currently in Phase 3 development. PRO 140 blocks the HIV co-receptor CCR5 on T cells, which prevents viral entry. Clinical trial results thus far indicate that PRO 140 does not negatively affect the normal immune functions that are mediated by CCR5. Results from seven Phase 1 and Phase 2 human clinical trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV. A recent Phase 2b clinical trial demonstrated that PRO 140 can prevent viral escape in patients during several months of interruption from conventional drug therapy.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $82.791B 32.99
Takeda Pharmaceutical (TAK) Japan $44.196B 8.85
Astellas Pharma (ALPMY) Japan $22.250B 20.49
Sandoz Group AG (SDZNY) Switzerland $19.619B 0.00
United Therapeutics (UTHR) United States $16.079B 15.87
Summit Therapeutics (SMMT) United States $13.513B 0.00
Shionogi (SGIOY) Japan $12.767B 12.23
Neurocrine Biosciences (NBIX) United States $12.554B 33.33
Catalent (CTLT) United States $10.704B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.989B 7.41
Orion OYJ (ORINY) Finland $6.848B 19.25
Ionis Pharmaceuticals (IONS) United States $5.740B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.521B 0.00
Corcept Therapeutics (CORT) United States $4.900B 37.21
Madrigal Pharmaceuticals (MDGL) United States $4.688B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.463B 0.00
PTC Therapeutics (PTCT) United States $3.128B 0.00
Dyne Therapeutics (DYN) United States $2.932B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.653B 15.30
Catalyst Pharmaceuticals (CPRX) United States $2.559B 20.34
Arrowhead Pharmaceuticals (ARWR) United States $2.450B 0.00
Soleno Therapeutics (SLNO) United States $2.166B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.878B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.732B 0.00
Ocular Therapeutix (OCUL) United States $1.728B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.710B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.620B 0.00
Harrow (HROW) United States $1.576B 0.00
Xencor (XNCR) United States $1.470B 0.00
Evotec AG (EVO) Germany $1.403B 0.00
Ardelyx (ARDX) United States $1.387B 0.00
ARS Pharmaceuticals (SPRY) United States $1.383B 0.00
Enliven Therapeutics (ELVN) United States $1.341B 0.00
Indivior (INDV) United States $1.282B 5.22
Cassava Sciences (SAVA) United States $1.247B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.243B 0.00
Collegium Pharmaceutical (COLL) United States $1.117B 6.41
Bioventus (BVS) United States $1.100B 35.74
Guardian Pharmacy Services (GRDN) United States $1.090B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.052B 0.00
Cronos Group (CRON) Canada $0.807B 0.00
Relay Therapeutics (RLAY) United States $0.765B 0.00
USANA Health Sciences (USNA) United States $0.700B 12.98
Tourmaline Bio (TRML) United States $0.679B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.663B 41.50
Exscientia (EXAI) United Kingdom $0.620B 0.00
Savara (SVRA) United States $0.599B 0.00
Korro Bio (KRRO) United States $0.566B 0.00
Larimar Therapeutics (LRMR) United States $0.540B 0.00
Silence Therapeutics (SLN) United Kingdom $0.519B 0.00
Aquestive Therapeutics (AQST) United States $0.514B 0.00
Siga Technologies (SIGA) United States $0.505B 6.05
Verve Therapeutics (VERV) United States $0.490B 0.00
ProKidney (PROK) United States $0.487B 0.00
KalVista Pharmaceuticals (KALV) United States $0.484B 0.00
Xeris Biopharma Holdings (XERS) United States $0.481B 0.00
Altimmune (ALT) United States $0.480B 0.00
OmniAb (OABI) United States $0.471B 0.00
Elite Pharmaceuticals (ELTP) United States $0.465B 43.50
Zevra Therapeutics (ZVRA) United States $0.444B 0.00
4D Molecular Therapeutics (FDMT) United States $0.430B 0.00
Esperion Therapeutics (ESPR) United States $0.418B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.414B 0.00
Sage Therapeutics (SAGE) United States $0.394B 0.00
Organogenesis (ORGO) United States $0.383B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.359B 0.00
Akebia Therapeutics (AKBA) United States $0.357B 0.00
Aldeyra Therapeutics (ALDX) United States $0.317B 0.00
Lexeo Therapeutics (LXEO) United States $0.274B 0.00
Heron Therapeutics (HRTX) United States $0.273B 0.00
Avita Medical (RCEL) United States $0.270B 0.00
Acrivon Therapeutics (ACRV) United States $0.259B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.251B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.243B 0.00
Nature's Sunshine Products (NATR) United States $0.240B 16.44
ESSA Pharma (EPIX) Canada $0.234B 0.00
Nektar Therapeutics (NKTR) United States $0.230B 0.00
Pyxis Oncology (PYXS) United States $0.224B 0.00
Lyell Immunopharma (LYEL) United States $0.220B 0.00
Nanobiotix S.A (NBTX) France $0.206B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.200B 0.00
MediWound (MDWD) Israel $0.195B 0.00
Profound Medical (PROF) Canada $0.184B 0.00
Innate Pharma SA (IPHYF) France $0.180B 0.00
Context Therapeutics (CNTX) United States $0.163B 0.00
Achieve Life Sciences (ACHV) Canada $0.162B 0.00
Fractyl Health (GUTS) United States $0.161B 0.00
Galectin Therapeutics (GALT) United States $0.157B 0.00
Cardiol Therapeutics (CRDL) Canada $0.145B 0.00
Incannex Healthcare (IXHL) Australia $0.144B 0.00
VAXART, INC (VXRT) United States $0.139B 0.00
Telomir Pharmaceuticals (TELO) United States $0.131B 0.00
Aclaris Therapeutics (ACRS) United States $0.128B 0.00
Journey Medical (DERM) United States $0.119B 0.00
Century Therapeutics (IPSC) United States $0.108B 0.00
OptiNose (OPTN) United States $0.106B 0.00
Relmada Therapeutics (RLMD) United States $0.106B 0.00
Karyopharm Therapeutics (KPTI) United States $0.105B 0.00
AlloVir (ALVR) United States $0.102B 0.00
Regulus Therapeutics (RGLS) United States $0.102B 0.00
Assertio Holdings (ASRT) United States $0.100B 17.50
CASI Pharmaceuticals (CASI) China $0.095B 0.00
Arch Biopartners (ACHFF) Canada $0.089B 0.00
PMV Pharmaceuticals (PMVP) United States $0.082B 0.00
Metagenomi (MGX) United States $0.079B 0.00
ElectroCore (ECOR) United States $0.077B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.67
Vivani Medical (VANI) United States $0.074B 0.00
Citius Pharmaceuticals (CTXR) United States $0.073B 0.00
Prelude Therapeutics (PRLD) United States $0.073B 0.00
Nutriband (NTRB) United States $0.069B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
Champions Oncology (CSBR) United States $0.052B 0.00
SCYNEXIS (SCYX) United States $0.051B 0.00
Protara Therapeutics (TARA) United States $0.048B 0.00
Unicycive Therapeutics (UNCY) United States $0.048B 0.00
Inotiv (NOTV) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
ProPhase Labs (PRPH) United States $0.043B 0.00
DURECT (DRRX) United States $0.042B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
Surrozen (SRZN) United States $0.036B 0.00
Oruka Therapeutics (ORKA) United States $0.035B 0.00
BioLineRx (BLRX) Israel $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
GlycoMimetics (GLYC) United States $0.029B 0.00
Lipocine (LPCN) United States $0.029B 0.00
Natural Alternatives (NAII) United States $0.029B 0.00
Iterum Therapeutics (ITRM) Ireland $0.027B 0.00
BioVie (BIVI) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 0.72
Inhibikase Therapeutics (IKT) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
Talphera (TLPH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.015B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.015B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Indaptus Therapeutics (INDP) United States $0.013B 0.00
CERo Therapeutics Holdings (CERO) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Conduit Pharmaceuticals (CDT) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.005B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.10
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Molecular Templates (MTEM) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.46
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 34.96